• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis.

作者信息

Sloan F A, Viscusi W K, Chesson H W, Conover C J, Whetten-Goldstein K

机构信息

Department of Economics, Duke University, Durham, NC 27708, USA.

出版信息

J Health Econ. 1998 Aug;17(4):475-97. doi: 10.1016/s0167-6296(97)00025-8.

DOI:10.1016/s0167-6296(97)00025-8
PMID:10180927
Abstract

This study uses both risk-risk and risk-dollar approaches to assess intangible health losses associated with multiple sclerosis (MS). Using an estimation approach that adjusts for potential perceptional biases that may effect the expressed risk tradeoffs, we estimated parameters of the utility function of persons with and without MS as well as the degree of subjects" overestimation of the probability of obtaining MS. The sample included subjects from the general population and persons with MS. We found that marginal utility of income is lower in the state with MS than without it. However, the difference in marginal in two states was greater for persons without MS than for those with the disease. Persons with MS overestimated the probability of acquiring MS to a greater extent than did persons within MS. Correcting for overestimation of this probability, the value of intangible loss of a statistical case of MS derived from responses of the general population was US$350,000 to US$500.000. Persons with MS were willing to pay somewhat more than this (D80,118,J17).

摘要

相似文献

1
Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis.
J Health Econ. 1998 Aug;17(4):475-97. doi: 10.1016/s0167-6296(97)00025-8.
2
Societal costs of multiple sclerosis in Ireland.爱尔兰多发性硬化症的社会成本。
J Med Econ. 2018 May;21(5):425-437. doi: 10.1080/13696998.2018.1427100. Epub 2018 Feb 7.
3
Costs and quality of life of multiple sclerosis in Germany.德国多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S34-44. doi: 10.1007/s10198-006-0384-8.
4
Costs and quality of life for patients with multiple sclerosis in Belgium.比利时多发性硬化症患者的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S24-33. doi: 10.1007/s10198-006-0377-7.
5
Costs and quality of life of multiple sclerosis in the United Kingdom.英国多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S96-104. doi: 10.1007/s10198-006-0380-z.
6
A cost evaluation of multiple sclerosis.多发性硬化症的成本评估。
J Neurovirol. 2000 May;6 Suppl 2:S191-3.
7
Costs and quality of life of multiple sclerosis in Sweden.瑞典多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S75-85. doi: 10.1007/s10198-006-0379-5.
8
Costs and quality of life of multiple sclerosis in Switzerland.瑞士多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S86-95. doi: 10.1007/s10198-006-0383-9.
9
Costs and quality of life in multiple sclerosis in The Netherlands.荷兰多发性硬化症的成本与生活质量。
Eur J Health Econ. 2006 Sep;7 Suppl 2:S55-64. doi: 10.1007/s10198-006-0378-6.
10
Costs and quality of life of multiple sclerosis in Italy.意大利多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S45-54. doi: 10.1007/s10198-006-0385-7.

引用本文的文献

1
Health Risk and the Value of Life.健康风险与生命价值。
J Public Econ. 2025 May;245. doi: 10.1016/j.jpubeco.2025.105346. Epub 2025 Apr 3.
2
Patient Preferences for Lung Cancer Interception Therapy.患者对肺癌干预疗法的偏好。
JAMA Netw Open. 2023 Nov 1;6(11):e2342681. doi: 10.1001/jamanetworkopen.2023.42681.
3
Vaccination under pessimistic expectations in clinical trials and immunization campaigns.在临床试验和免疫接种活动中,在悲观预期下进行疫苗接种。
J Public Econ Theory. 2022 Sep 18. doi: 10.1111/jpet.12617.
4
Hesitancy Toward a COVID-19 Vaccine.对 COVID-19 疫苗的犹豫。
Ecohealth. 2021 Mar;18(1):44-60. doi: 10.1007/s10393-021-01524-0. Epub 2021 Jun 4.
5
How Does Health Status Affect Marginal Utility of Consumption? Evidence from China.健康状况如何影响消费的边际效用?来自中国的证据。
Int J Environ Res Public Health. 2020 Mar 26;17(7):2234. doi: 10.3390/ijerph17072234.
6
Household Labor Supply and the Gains from Social Insurance.家庭劳动力供给与社会保险收益
J Public Econ. 2019 Mar;171:18-28. doi: 10.1016/j.jpubeco.2018.01.010. Epub 2018 Feb 2.
7
Advantageous Selection, Moral Hazard, and Insurer Sorting on Risk in the U.S. Automobile Insurance Market.美国汽车保险市场中的有利选择、道德风险与保险公司的风险分类
J Risk Insur. 2018 Jun;85(2):545-575. doi: 10.1111/jori.12170. Epub 2016 Nov 28.
8
Baseline risk and marginal willingness to pay for health risk reduction.基线风险与降低健康风险的边际支付意愿。
J Risk Uncertain. 2017;55(2):177-202. doi: 10.1007/s11166-017-9267-x. Epub 2017 Dec 13.
9
New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year.从收入时间权衡法得出的新发现,用于引出对质量调整生命年的支付意愿。
Eur J Health Econ. 2018 Mar;19(2):277-291. doi: 10.1007/s10198-017-0883-9. Epub 2017 Mar 8.
10
Do preferences of drinker-drivers differ?酒后驾车者的偏好是否存在差异?
Int J Health Econ Manag. 2015 Jun;15(2):241-268. doi: 10.1007/s10754-015-9169-x. Epub 2015 Mar 22.